Brief: Titan Pharmaceuticals Inc Says Co Received Letter From Nasdaq Confirming It Has Regained Compliance With Nasdaq Listing Standards
16/12/2020 13:29
Dec 16 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS INC - ON DEC 15, 2020, CO RECEIVED
LETTER
FROM NASDAQ CONFIRMING THAT CO HAS REGAINED COMPLIANCE WITH
NASDAQ LISTING STANDARDS
Source text for Eikon: ID:nPn3xx87ra
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.